Marzo, Manuela
 Distribuzione geografica
Continente #
EU - Europa 921
NA - Nord America 845
AS - Asia 186
AF - Africa 2
OC - Oceania 1
Totale 1.955
Nazione #
US - Stati Uniti d'America 841
DE - Germania 445
SE - Svezia 126
CN - Cina 111
UA - Ucraina 89
IT - Italia 72
FR - Francia 55
GB - Regno Unito 46
IE - Irlanda 34
IN - India 31
FI - Finlandia 21
SG - Singapore 19
TR - Turchia 13
BE - Belgio 10
RU - Federazione Russa 9
IR - Iran 7
CA - Canada 4
JP - Giappone 3
PL - Polonia 3
CH - Svizzera 2
CI - Costa d'Avorio 2
GR - Grecia 2
NL - Olanda 2
TW - Taiwan 2
AU - Australia 1
BG - Bulgaria 1
EE - Estonia 1
HU - Ungheria 1
ME - Montenegro 1
RO - Romania 1
Totale 1.955
Città #
Chandler 202
Jacksonville 78
Ashburn 61
Dearborn 54
Ann Arbor 49
San Mateo 42
New York 40
Cattolica 34
Dublin 33
Nürnberg 26
Nanjing 24
Wilmington 22
Munich 20
Bremen 19
Beijing 18
Milan 16
Lawrence 15
Izmir 13
Houston 12
Singapore 12
Lancaster 11
Brussels 10
Boston 9
Jiaxing 7
Leawood 7
Moscow 7
Nanchang 7
Seattle 7
Shenyang 7
Woodbridge 7
Ardabil 6
Fairfield 6
Boardman 5
Mountain View 5
Marseille 4
Princeton 4
Redwood City 4
Shanghai 4
Augusta 3
Changsha 3
Costa Mesa 3
Detroit 3
Edinburgh 3
Hangzhou 3
Hebei 3
Hefei 3
Helsinki 3
Kraków 3
Millbury 3
Tianjin 3
University Park 3
Abidjan 2
Andover 2
Changchun 2
Fremont 2
Guangzhou 2
Jinan 2
Lanzhou 2
Los Angeles 2
Napoli 2
Norwalk 2
Pune 2
Rome 2
Taipei 2
Toronto 2
Ahmedabad 1
Amsterdam 1
Athens 1
Bern 1
Budapest 1
Canberra 1
Clearwater 1
Delhi 1
Easton 1
Fuzhou 1
Indiana 1
Ipswich 1
Kish 1
Kunming 1
Kyiv 1
Ladispoli 1
Landshut 1
London 1
Moncalieri 1
Monmouth Junction 1
Montreal 1
Montréal 1
Novara 1
Ocean Grove 1
Pittsburgh 1
Podgorica 1
Quzhou 1
Raritan 1
Ribera 1
Sacramento 1
San Jose 1
Shaoxing 1
Simi Valley 1
Sofia 1
Tallinn 1
Totale 1.009
Nome #
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 149
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 139
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 139
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 133
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 132
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 130
Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab 117
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 115
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents 109
Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease. 102
Ileal Crohn's disease: CEUS determination of activity 100
Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity 94
Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity 87
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 83
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 80
Management of perianal fistulas in Crohn's disease: an up-to-date review 71
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? 71
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 68
Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis. 48
Totale 1.967
Categoria #
all - tutte 5.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020333 51 12 41 14 28 57 26 13 26 9 33 23
2020/2021167 4 19 3 22 22 3 13 9 24 2 41 5
2021/2022218 31 18 4 39 7 2 3 39 4 3 30 38
2022/2023462 61 64 21 100 33 54 16 36 61 2 8 6
2023/2024187 10 46 2 16 2 42 3 25 2 5 15 19
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 1.967